Erratum
21 May 2019
Erratum
21 May 2019
Splenectomy as Flow Modulation Strategy and Risk Factors of De Novo Portal Vein Thrombosis in Adult‐to‐Adult Living Donor Liver Transplantation
Toru Ikegami, Tomoharu Yoshizumi, Norifumi Harimoto, Masaki Mori – 20 May 2019
Macrophage Nourishment in Nonalcoholic Steatohepatitis: A Novel Role for Ketone Bodies
Natalie J. Torok – 20 May 2019
Quality Measures, All‐Cause Mortality, and Health Care Use in a National Cohort of Veterans With Cirrhosis
Marina Serper, David E. Kaplan, Justine Shults, Peter P. Reese, Lauren A. Beste, Tamar H. Taddei, Rachel M. Werner – 20 May 2019 – Decompensated cirrhosis is associated with high morbidity and mortality. However, no standardized quality measures (QMs) have yet been adopted widely.
Clinical Utility of a Risk‐Adapted Protocol for the Evaluation of Coronary Artery Disease in Liver Transplant Recipients
Mario Romero‐Cristóbal, Teresa Mombiela, Aranzazu Caballero, Ana Clemente, Ainhoa Fernández‐Yunquera, Fernando Diaz‐Fontenla, Diego Rincón, Cristina Ripoll, Javier Bermejo, María‐Vega Catalina, Ana‐María Matilla, Luis Ibáñez‐Samaniego, José Pérez‐Peña, José‐Ángel López‐Baena, Benjamín Díaz‐Zorita, Francisco Fernández‐Avilés, M. Magdalena Salcedo, Rafael Bañares – 20 May 2019 – The prevalence and management of coronary artery disease (CAD) in liver transplantation (LT) candidates are not well characterized.
Identification of Factors Affecting Tacrolimus Trough Levels in Latin American Pediatric Liver Transplant Patients
Natalia Riva, Jean‐Baptiste Woillard, Maximiliano Distefano, Matias Moragas, Marcelo Dip, Esteban Halac, Paulo Cáceres Guido, Nieves Licciardone, Andrea Mangano, Andrea Bosaleh, María Teresa Davila, Paula Schaiquevich, Oscar Imventarza – 18 May 2019 – Tacrolimus is the cornerstone in pediatric liver transplant immunosuppression. Despite close monitoring, fluctuations in tacrolimus blood levels affect safety and efficacy of immunosuppressive treatments. Identifying the factors related to the variability in tacrolimus exposure may be helpful in tailoring the dose.
Glucose‐6‐Phosphate Regulates Hepatic Bile Acid Synthesis in Mice
Joanne A. Hoogerland, Yu Lei, Justina C. Wolters, Jan Freark Boer, Trijnie Bos, Aycha Bleeker, Niels L. Mulder, Theo H. Dijk, Jan A. Kuivenhoven, Fabienne Rajas, Gilles Mithieux, Rebecca A. Haeusler, Henkjan J. Verkade, Vincent W. Bloks, Folkert Kuipers, Maaike H. Oosterveer – 18 May 2019 – It is well established that, besides facilitating lipid absorption, bile acids act as signaling molecules that modulate glucose and lipid metabolism. Bile acid metabolism, in turn, is controlled by several nutrient‐sensitive transcription factors.
Cystic Fibrosis–Associated Liver Disease in Lung Transplant Recipients
Jorge Mallea, Candice Bolan, Cherise Cortese, Denise Harnois – 18 May 2019 – Cystic fibrosis (CF) is an autosomal recessive disease characterized by mutations in the gene that encodes for the cystic fibrosis transmembrane conductance regulator protein (CFTR). CFTR gene mutations manifest as epithelial cell dysfunction in the airways, biliary tract, pancreas, gut, sweat glands, paranasal sinuses, and genitourinary tract.